Express Scripts Rises as Profit Forecast Beats Estimates
This article is for subscribers only.
Express Scripts Holding Co. rose after the largest U.S. processor of drug prescriptions gave a profit forecast that exceeded analysts’ lowered estimates.
Express Scripts gained 2.5 percent to $56.98 at the close in New York, its highest share price since Nov. 5. The company’s shares have gained 9.2 percent in the past 12 months.